|
|
Volumn 9, Issue 2, 2000, Pages 207-220
|
|
Therapeutic developments in cytomegalovirus retinitis
|
|
Author keywords
Adefovir; BAY 38 4766; Cidofovir; Cyclic hpmpc; Cytomegalovirus retinitis; Drug therapy; Fomivirsen; Foscarnet; Ganciclovir; GW1263W94; HIV infection; Lobucavir; MSL 109; Valganciclovir
|
|
Indexed keywords
ADEFOVIR;
ANTIRETROVIRUS AGENT;
BENZIMIDAVIR;
CIDOFOVIR;
FOMIVIRSEN;
FOSCARNET;
GANCICLOVIR;
LOBUCAVIR;
SEVIRUMAB;
TOMEGLOVIR;
UNCLASSIFIED DRUG;
VALGANCICLOVIR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BLINDNESS;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG RESISTANCE;
DRUG TOLERABILITY;
ENDOPHTHALMITIS;
EYE TOXICITY;
GASTROINTESTINAL SYMPTOM;
HEPATITIS B;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPOCALCEMIA;
HYPOKALEMIA;
META ANALYSIS;
NEPHROTOXICITY;
RETINITIS;
REVIEW;
SIDE EFFECT;
VIRUS RESISTANCE;
|
|
EID: 0033982822
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.2.207 Document Type: Review |
|
Times cited : (30)
|
|
References (91)
|
